{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:02:09Z","timestamp":1792202529001,"version":"4.4.0"},"reference-count":78,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CSCR"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Moyamoya disease (MMD) is a chronic steno-occlusion cerebrovascular disease accompanied\nby the formation of the abnormal vascular network at the base of the brain. The etiology of MMD is not\nfully clarified. Lack of pathological specimens hinders the research progress. Induced pluripotent stem\ncells (iPSC) derived from patients with outstanding differentiation potential and infinite proliferation\nability could conquer the problem of insufficient samples. The technology of iPSC holds the promise of\nclarifying the underlying molecular mechanism in the development of MMD. In this review, we summarized\nthe latest progress and difficulties in the research of mechanism and detailed the application of iPSC\nin MMD, aiming to provide an outlook of iPSC in molecular mechanism and novel therapies of MMD.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574888x17666220607121027","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T11:39:24Z","timestamp":1654688364000},"page":"733-739","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Application of Induced Pluripotent Stem Cells in Moyamoya Disease:\nProgress and Promises"],"prefix":"10.2174","volume":"18","author":[{"given":"Yimeng","family":"Xue","sequence":"first","affiliation":[{"name":"Savaid Medical School, University of Chinese Academy of Sciences, Beijing China"},{"name":"Department of Neurosurgery, Beijing\nTiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Beijing\nTiantan Hospital, Capital Medical University, Beijing, China"},{"name":"Center of Stroke, Beijing Institute for Brain Disorders,\nBeijing, China"},{"name":"Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Jian","family":"Wang","sequence":"additional","affiliation":[{"name":"Savaid Medical School, University of Chinese Academy of Sciences, Beijing China"},{"name":"Department of Neurosurgery, Beijing\nTiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jun","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Beijing\nTiantan Hospital, Capital Medical University, Beijing, China"},{"name":"Institute of Radiation Medicine,\nChinese Academy of Medical Science &amp; Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Savaid Medical School, University of Chinese Academy of Sciences, Beijing China"},{"name":"Department of Neurosurgery, Beijing\nTiantan Hospital, Capital Medical University, Beijing, China"},{"name":"Center of Stroke, Beijing Institute for Brain Disorders,\nBeijing, China"},{"name":"Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China"},{"name":"China National Clinical Research Center for Neurological Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","volume":"20","author":"Suzuki J.","year":"1969","unstructured":"Suzuki J.; Takaku A.; Cerebrovascular \u201cmoyamoya\u201d disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969,20(3),288-299","journal-title":"Arch Neurol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/STROKEAHA.117.018563","volume":"49","author":"Acker G.","year":"2018","unstructured":"Acker G.; Fekonja L.; Vajkoczy P.; Surgical management of moyamoya disease. Stroke 2018,49(2),476-482","journal-title":"Stroke"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1159\/000442298","volume":"41","author":"Bersano A.","year":"2016","unstructured":"Bersano A.; Guey S.; Bedini G.; European moyamoya disease initiative. Research progresses in understanding the pathophysiology of moyamoya disease. Cerebrovasc Dis 2016,41(3-4),105-118","journal-title":"Cerebrovasc Dis"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13287-017-0642-y","volume":"8","author":"Wang Y.","year":"2017","unstructured":"Wang Y.; Yin P.; Bian G.L.; The combination of stem cells and tissue engineering: An advanced strategy for blood vessels regeneration and vascular disease treatment. Stem Cell Res Ther 2017,8(1),194","journal-title":"Stem Cell Res Ther"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.celrep.2017.04.021","volume":"19","author":"Lim R.G.","year":"2017","unstructured":"Lim R.G.; Quan C.; Reyes-Ortiz A.M.; Huntington\u2019s disease iPSC-derived brain microvascular endothelial cells reveal WNT-mediated angiogenic and blood-brain barrier deficits. Cell Rep 2017,19(7),1365-1377","journal-title":"Cell Rep"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1136\/jnnp.2007.130666","volume":"79","author":"Baba T.","year":"2008","unstructured":"Baba T.; Houkin K.; Kuroda S.; Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 2008,79(8),900-904","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1161\/STROKEAHA.113.004273","volume":"45","author":"Ahn I.M.","year":"2014","unstructured":"Ahn I.M.; Park D.H.; Hann H.J.; Kim K.H.; Kim H.J.; Ahn H.S.; Incidence, prevalence, and survival of moyamoya disease in Korea: A nationwide, population-based study. Stroke 2014,45(4),1090-1095","journal-title":"Stroke"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.clineuro.2009.11.009","volume":"112","author":"Miao W.","year":"2010","unstructured":"Miao W.; Zhao P.L.; Zhang Y.S.; Epidemiological and clinical features of Moyamoya disease in Nanjing, China. Clin Neurol Neurosurg 2010,112(3),199-203","journal-title":"Clin Neurol Neurosurg"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1159\/000345957","volume":"40","author":"Kainth D.","year":"2013","unstructured":"Kainth D.; Chaudhry S.A.; Kainth H.; Suri F.K.; Qureshi A.I.; Epidemiological and clinical features of moyamoya disease in the USA. Neuroepidemiology 2013,40(4),282-287","journal-title":"Neuroepidemiology"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"61-4","DOI":"10.1046\/j.1440-1789.2000.00300.x","volume":"20","author":"Fukui M","year":"2000","unstructured":"Fukui M; Kono S; Sueishi K; Ikezaki K.;  Moyamoya disease 2000,20(s1),61-4","journal-title":"Moyamoya disease"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1440-1789.2004.00550.x","volume":"24","author":"Takekawa Y.","year":"2004","unstructured":"Takekawa Y.; Umezawa T.; Ueno Y.; Sawada T.; Kobayashi M.; Pathological and immunohistochemical findings of an autopsy case of adult moyamoya disease. Neuropathology. Official J Japanese Society Neuropathol 2004,24(3),236-242","journal-title":"Official J Japanese Society Neuropathol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1038\/s41598-021-81282-9","volume":"11","author":"Matsuo M.","year":"2021","unstructured":"Matsuo M.; Nadanaka S.; Soga M.; Vulnerability to shear stress caused by altered peri-endothelial matrix is a key feature of Moyamoya disease. Sci Rep 2021,11(1),1552","journal-title":"Sci Rep"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1161\/STROKEAHA.111.000307","volume":"44","author":"Bower R.S.","year":"2013","unstructured":"Bower R.S.; Mallory G.W.; Nwojo M.; Kudva Y.C.; Flemming K.D.; Meyer F.B.; Moyamoya disease in a primarily white, midwestern US population: Increased prevalence of autoimmune disease. Stroke 2013,44(7),1997-1999","journal-title":"Stroke"},{"key":"ref=14","first-page":"STROKEAHA120032297","author":"Wang X.","year":"2021","unstructured":"Wang X.; Han C.; Jia Y.; Wang J.; Ge W.; Duan L.; Proteomic profiling of exosomes from hemorrhagic moyamoya disease and dysfunction of mitochondria in endothelial cells. Stroke 2021,STROKEAHA120032297","journal-title":"Stroke"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3390\/cells10051086","volume":"10","author":"Li L.","year":"2021","unstructured":"Li L.; Liu P.; Wang R.; Pathophysiological significance of neutrophilic transfer RNA-derived small RNAs in asymptomatic moyamoya disease. Cells 2021,10(5),1086","journal-title":"Cells"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ajhg.2009.04.007","volume":"84","author":"Guo D.C.","year":"2009","unstructured":"Guo D.C.; Papke C.L.; Tran-Fadulu V.; Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet 2009,84(5),617-627","journal-title":"Am J Hum Genet"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1086\/302243","volume":"64","author":"Ikeda H.","year":"1999","unstructured":"Ikeda H.; Sasaki T.; Yoshimoto T.; Fukui M.; Arinami T.; Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet 1999,64(2),533-537","journal-title":"Am J Hum Genet"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/088307380001500307","volume":"15","author":"Inoue T.K.","year":"2000","unstructured":"Inoue T.K.; Ikezaki K.; Sasazuki T.; Matsushima T.; Fukui M.; Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol 2000,15(3),179-182","journal-title":"J Child Neurol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s10038-004-0143-6","volume":"49","author":"Sakurai K.","year":"2004","unstructured":"Sakurai K.; Horiuchi Y.; Ikeda H.; A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet 2004,49(5),278-281","journal-title":"J Hum Genet"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1161\/01.STR.31.4.930","volume":"31","author":"Yamauchi T.","year":"2000","unstructured":"Yamauchi T.; Tada M.; Houkin K.; Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 2000,31(4),930-935","journal-title":"Stroke"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"e22542","DOI":"10.1371\/journal.pone.0022542","volume":"6","author":"Liu W.","year":"2011","unstructured":"Liu W.; Morito D.; Takashima S.; Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 2011,6(7),e22542","journal-title":"PLoS One"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00701-019-03811-w","volume":"161","author":"Narducci A.","year":"2019","unstructured":"Narducci A.; Yasuyuki K.; Onken J.; Blecharz K.; Vajkoczy P.; In vivo demonstration of blood-brain barrier impairment in Moyamoya disease. Acta Neurochir (Wien) 2019,161(2),371-378","journal-title":"Acta Neurochir (Wien)"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1001\/jamaneurol.2021.1681","volume":"78","author":"Kundishora A.J.","year":"2021","unstructured":"Kundishora A.J.; Peters S.T.; Pinard A.; DIAPH1 variants in non-east asian patients with sporadic moyamoya disease. JAMA Neurol 2021,78(8),993-1003","journal-title":"JAMA Neurol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1212\/WNL.0b013e318249f71f","volume":"78","author":"Miyatake S.","year":"2012","unstructured":"Miyatake S.; Miyake N.; Touho H.; Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology 2012,78(11),803-810","journal-title":"Neurology"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1161\/STROKEAHA.114.006244","volume":"45","author":"Cecchi A.C.","year":"2014","unstructured":"Cecchi A.C.; Guo D.; Ren Z.; RNF213 rare variants in an ethnically diverse population with Moyamoya disease. Stroke 2014,45(11),3200-3207","journal-title":"Stroke"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.brainres.2016.04.051","volume":"1644","author":"Wen J.","year":"2016","unstructured":"Wen J.; Sun X.; Chen H.; Mutation of rnf213a by TALEN causes abnormal angiogenesis and circulation defects in zebrafish. Brain Res 2016,1644,70-78","journal-title":"Brain Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1006\/dbio.2002.0711","volume":"248","author":"Lawson N.D.","year":"2002","unstructured":"Lawson N.D.; Weinstein B.M.; In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol 2002,248(2),307-318","journal-title":"Dev Biol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.bbrc.2013.02.015","volume":"432","author":"Kobayashi H.","year":"2013","unstructured":"Kobayashi H.; Yamazaki S.; Takashima S.; Ablation of Rnf213 retards progression of diabetes in the Akita mouse. Biochem Biophys Res Commun 2013,432(3),519-525","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.brainres.2014.01.011","volume":"1552","author":"Sonobe S.","year":"2014","unstructured":"Sonobe S.; Fujimura M.; Niizuma K.; Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking RNF213: A susceptibility gene for moyamoya disease. Brain Res 2014,1552,64-71","journal-title":"Brain Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"e002146","DOI":"10.1161\/JAHA.115.002146","volume":"4","author":"Kobayashi H.","year":"2015","unstructured":"Kobayashi H.; Matsuda Y.; Hitomi T.; Biochemical and functional characterization of RNF213 (Mysterin) R4810K, a susceptibility mutation of moyamoya disease, in angiogenesis in vitro and in vivo. J Am Heart Assoc 2015,4(7),e002146","journal-title":"J Am Heart Assoc"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.brainres.2015.10.055","volume":"1630","author":"Sato-Maeda M.","year":"2016","unstructured":"Sato-Maeda M.; Fujimura M.; Kanoke A.; Morita-Fujimura Y.; Niizuma K.; Tominaga T.; Transient middle cerebral artery occlusion in mice induces neuronal expression of RNF213, a susceptibility gene for moyamoya disease. Brain Res 2016,1630,50-55","journal-title":"Brain Res"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1097\/WNR.0000000000000289","volume":"25","author":"Sonobe S.","year":"2014","unstructured":"Sonobe S.; Fujimura M.; Niizuma K.; Increased vascular MMP-9 in mice lacking RNF213: Moyamoya disease susceptibility gene. Neuroreport 2014,25(18),1442-1446","journal-title":"Neuroreport"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"Takahashi K.","year":"2007","unstructured":"Takahashi K.; Tanabe K.; Ohnuki M.; Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007,131(5),861-872","journal-title":"Cell"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.stem.2013.05.016","volume":"12","author":"Merkle F.T.","year":"2013","unstructured":"Merkle F.T.; Eggan K.; Modeling human disease with pluripotent stem cells: From genome association to function. Cell Stem Cell 2013,12(6),656-668","journal-title":"Cell Stem Cell"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ajpath.2018.12.004","volume":"189","author":"Jang S.","year":"2019","unstructured":"Jang S.; Collin de l\u2019Hortet A.; Soto-Gutierrez A.; Induced pluripotent stem cell-derived endothelial cells: Overview, current advances, applications, and future directions. Am J Pathol 2019,189(3),502-512","journal-title":"Am J Pathol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bbrc.2013.07.004","volume":"438","author":"Hitomi T.","year":"2013","unstructured":"Hitomi T.; Habu T.; Kobayashi H.; Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients. Biochem Biophys Res Commun 2013,438(1),13-19","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bbrc.2013.08.067","volume":"439","author":"Hitomi T.","year":"2013","unstructured":"Hitomi T.; Habu T.; Kobayashi H.; The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality. Biochem Biophys Res Commun 2013,439(4),419-426","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.scr.2016.11.006","volume":"17","author":"Cardano M.","year":"2016","unstructured":"Cardano M.; Marsoner F.; Marcatili M.; Establishment of induced pluripotent stem cell (iPSC) line from 55-year old male patient with hemorrhagic Moyamoya disease. Stem Cell Res (Amst) 2016,17(3),623-626","journal-title":"Stem Cell Res (Amst)"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.scr.2016.11.007","volume":"17","author":"Cardano M.","year":"2016","unstructured":"Cardano M.; Marsoner F.; Zasso J.; Establishment of induced pluripotent stem cell (iPSC) line from an 8-year old female patient with ischemic Moyamoya disease. Stem Cell Res (Amst) 2016,17(3),619-622","journal-title":"Stem Cell Res (Amst)"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"e0163561","DOI":"10.1371\/journal.pone.0163561","volume":"11","author":"Hamauchi S.","year":"2016","unstructured":"Hamauchi S.; Shichinohe H.; Uchino H.; Cellular functions and gene and protein expression profiles in endothelial cells derived from moyamoya disease-specific iPS cells. PLoS One 2016,11(9),e0163561","journal-title":"PLoS One"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41576-019-0100-z","volume":"20","author":"Rowe R.G.","year":"2019","unstructured":"Rowe R.G.; Daley G.Q.; Induced pluripotent stem cells in disease modelling and drug discovery. Nat Rev Genet 2019,20(7),377-388","journal-title":"Nat Rev Genet"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12920-018-0385-3","volume":"11","author":"Uchino H.","year":"2018","unstructured":"Uchino H.; Ito M.; Kazumata K.; Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins and endothelial microRNA expression analysis using iPS cell line. BMC Med Genomics 2018,11(1),72","journal-title":"BMC Med Genomics"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1161\/01.STR.24.12.1960","volume":"24","author":"Masuda J.","year":"1993","unstructured":"Masuda J.; Ogata J.; Yutani C.; Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in moyamoya disease. Stroke 1993,24(12),1960-1967","journal-title":"Stroke"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"e36386","DOI":"10.1371\/journal.pone.0036386","volume":"7","author":"Lin R.","year":"2012","unstructured":"Lin R.; Xie Z.; Zhang J.; Clinical and immunopathological features of moyamoya disease. PLoS One 2012,7(4),e36386","journal-title":"PLoS One"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3171\/2013.9.JNS131000","volume":"120","author":"Kang H.S.","year":"2014","unstructured":"Kang H.S.; Moon Y.J.; Kim Y.Y.; Smooth-muscle progenitor cells isolated from patients with moyamoya disease: Novel experimental cell model. J Neurosurg 2014,120(2),415-425","journal-title":"J Neurosurg"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"105305","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105305","volume":"29","author":"Tokairin K","year":"2020","unstructured":"Tokairin K; Hamauchi S; Ito M; Vascular smooth muscle cell derived from IPS cell of moyamoya disease-comparative characterization with endothelial cell transcriptome. J Stroke Cerebrovas Dis: The official journal of National Stroke Association 2020,29(12),105305","journal-title":"J Stroke Cerebrovas Dis: The official journal of National Stroke Association"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.2353\/ajpath.2006.060116","volume":"169","author":"Milliat F.","year":"2006","unstructured":"Milliat F.; Fran\u00e7ois A.; Isoir M.; Influence of endothelial cells on vascular smooth muscle cells phenotype after irradiation: Implication in radiation-induced vascular damages. Am J Pathol 2006,169(4),1484-1495","journal-title":"Am J Pathol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nbt.2107","volume":"30","author":"Cheung C.","year":"2012","unstructured":"Cheung C.; Bernardo A.S.; Trotter M.W.; Pedersen R.A.; Sinha S.; Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility. Nat Biotechnol 2012,30(2),165-173","journal-title":"Nat Biotechnol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/cne.1423","volume":"442","author":"Korn J.","year":"2002","unstructured":"Korn J.; Christ B.; Kurz H.; Neuroectodermal origin of brain pericytes and vascular smooth muscle cells. J Comp Neurol 2002,442(1),78-88","journal-title":"J Comp Neurol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1242\/dev.128.7.1059","volume":"128","author":"Etchevers H.C.","year":"2001","unstructured":"Etchevers H.C.; Vincent C.; Le Douarin N.M.; Couly G.F.; The cephalic neural crest provides pericytes and smooth muscle cells to all blood vessels of the face and forebrain. Development 2001,128(7),1059-1068","journal-title":"Development"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/BF00318497","volume":"279","author":"Ehler E.","year":"1995","unstructured":"Ehler E.; Karlhuber G.; Bauer H.C.; Draeger A.; Heterogeneity of smooth muscle-associated proteins in mammalian brain microvasculature. Cell Tissue Res 1995,279(2),393-403","journal-title":"Cell Tissue Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"16161","DOI":"10.1038\/srep16161","volume":"5","author":"Kotani Y.","year":"2015","unstructured":"Kotani Y.; Morito D.; Yamazaki S.; Neuromuscular regulation in zebrafish by a large AAA+ ATPase\/ubiquitin ligase, mysterin\/RNF213. Sci Rep 2015,5(1),16161","journal-title":"Sci Rep"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1073\/pnas.1222878110","volume":"110","author":"Seok J.","year":"2013","unstructured":"Seok J.; Warren H.S.; Cuenca A.G.; Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 2013,110(9),3507-3512","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1177\/0271678X16658301","volume":"37","author":"Blecharz K.G.","year":"2017","unstructured":"Blecharz K.G.; Frey D.; Schenkel T.; Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in Moyamoya disease. J Cereb Blood Flow Metab 2017,37(4),1527-1539","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1161\/STROKEAHA.108.529420","volume":"40","author":"Rafat N.","year":"2009","unstructured":"Rafat N.; Beck G.Ch.; Pe\u00f1a-Tapia P.G.; Schmiedek P.; Vajkoczy P.; Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease. Stroke 2009,40(2),432-438","journal-title":"Stroke"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1007\/s00701-012-1472-4","volume":"154","author":"Kaku Y.","year":"2012","unstructured":"Kaku Y.; Morioka M.; Ohmori Y.; Outer-diameter narrowing of the internal carotid and middle cerebral arteries in moyamoya disease detected on 3D constructive interference in steady-state MR image: Is arterial constrictive remodeling a major pathogenesis? Acta Neurochir (Wien) 2012,154(12),2151-2157","journal-title":"Acta Neurochir (Wien)"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2014.11.003","volume":"125","author":"Hopkins A.M.","year":"2015","unstructured":"Hopkins A.M.; DeSimone E.; Chwalek K.; Kaplan D.L.; 3D in vitro modeling of the central nervous system. Prog Neurobiol 2015,125,1-25","journal-title":"Prog Neurobiol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.116.305368","volume":"116","author":"Psaltis P.J.","year":"2015","unstructured":"Psaltis P.J.; Simari R.D.; Vascular wall progenitor cells in health and disease. Circ Res 2015,116(8),1392-1412","journal-title":"Circ Res"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1038\/s41596-019-0213-z","volume":"14","author":"Wimmer R.A.","year":"2019","unstructured":"Wimmer R.A.; Leopoldi A.; Aichinger M.; Kerjaschki D.; Penninger J.M.; Generation of blood vessel organoids from human pluripotent stem cells. Nat Protoc 2019,14(11),3082-3100","journal-title":"Nat Protoc"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature12517","volume":"501","author":"Lancaster M.A.","year":"2013","unstructured":"Lancaster M.A.; Renner M.; Martin C.A.; Cerebral organoids model human brain development and microcephaly. Nature 2013,501(7467),373-379","journal-title":"Nature"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/nbt.4127","volume":"36","author":"Mansour A.A.","year":"2018","unstructured":"Mansour A.A.; Gon\u00e7alves J.T.; Bloyd C.W.; An in vivo model of functional and vascularized human brain organoids. Nat Biotechnol 2018,36(5),432-441","journal-title":"Nat Biotechnol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/s41592-019-0586-5","volume":"16","author":"Cakir B.","year":"2019","unstructured":"Cakir B.; Xiang Y.; Tanaka Y.; Engineering of human brain organoids with a functional vascular-like system. Nat Methods 2019,16(11),1169-1175","journal-title":"Nat Methods"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/WNR.0000000000001014","volume":"29","author":"Pham M.T.","year":"2018","unstructured":"Pham M.T.; Pollock K.M.; Rose M.D.; Generation of human vascularized brain organoids. Neuroreport 2018,29(7),588-593","journal-title":"Neuroreport"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"15663","DOI":"10.1038\/s41598-019-52204-7","volume":"9","author":"W\u00f6rsd\u00f6rfer P.","year":"2019","unstructured":"W\u00f6rsd\u00f6rfer P.; Dalda N.; Kern A.; Generation of complex human organoid models including vascular networks by incorporation of mesodermal progenitor cells. Sci Rep 2019,9(1),15663","journal-title":"Sci Rep"},{"key":"ref=65","first-page":"1467-72","volume":"55","author":"Kim Y I","year":"2014","unstructured":"Kim Y I; Phi J H; Paeng J C; In vivo evaluation of angiogenic activity and its correlation with efficacy of indirect revascularization surgery in pediatric moyamoya disease. J Nuc Medi: Official publication, Society of Nuclear Medicine 2014,55(9),1467-72","journal-title":"J Nuc Medi: Official publication, Society of Nuclear Medicine"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5853\/jos.2015.01739","volume":"18","author":"Kim T.","year":"2016","unstructured":"Kim T.; Oh C.W.; Bang J.S.; Kim J.E.; Cho W.S.; Moyamoya Disease: Treatment and Outcomes. J Stroke 2016,18(1),21-30","journal-title":"J Stroke"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1161\/STROKEAHA.118.022490","volume":"50","author":"Jeon C.","year":"2019","unstructured":"Jeon C.; Yeon J.Y.; Jo K.I.; Hong S.C.; Kim J.S.; Clinical role of microembolic signals in adult moyamoya disease with ischemic stroke. Stroke 2019,50(5),1130-1135","journal-title":"Stroke"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5853\/jos.2015.01760","volume":"18","author":"Bang O.Y.","year":"2016","unstructured":"Bang O.Y.; Fujimura M.; Kim S.K.; The Pathophysiology of Moyamoya Disease: An Update. J Stroke 2016,18(1),12-20","journal-title":"J Stroke"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.stem.2019.05.011","volume":"24","author":"Vatine G.","year":"2019","unstructured":"Vatine G.; Barrile R.; Workman M.; Human iPSC-derived blood-brain barrier chips enable disease modeling and personalized medicine applications. Cell Stem Cell 2019,24(6),995-1005","journal-title":"Cell Stem Cell"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"E966","DOI":"10.3390\/cells9040966","volume":"9","author":"Dash B.C.","year":"2020","unstructured":"Dash B.C.; Setia O.; Gorecka J.; A dense fibrillar collagen scaffold differentially modulates secretory function of iPSC-derived vascular smooth muscle cells to promote wound healing. Cells 2020,9(4),E966","journal-title":"Cells"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.biomaterials.2017.09.019","volume":"147","author":"Luo J.","year":"2017","unstructured":"Luo J.; Qin L.; Kural M.H.; Vascular smooth muscle cells derived from inbred swine induced pluripotent stem cells for vascular tissue engineering. Biomaterials 2017,147,116-132","journal-title":"Biomaterials"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/term.1781","volume":"10","author":"Weber B.","year":"2016","unstructured":"Weber B.; Kehl D.; Bleul U.; In vitro fabrication of autologous living tissue-engineered vascular grafts based on prenatally harvested ovine amniotic fluid-derived stem cells. J Tissue Eng Regen Med 2016,10(1),52-70","journal-title":"J Tissue Eng Regen Med"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1517\/14712598.2016.1118460","volume":"16","author":"Wang L.","year":"2016","unstructured":"Wang L.; Hu J.; Sorek C.E.; Chen E.Y.; Ma P.X.; Yang B.; Fabrication of tissue-engineered vascular grafts with stem cells and stem cell-derived vascular cells. Expert Opin Biol Ther 2016,16(3),317-330","journal-title":"Expert Opin Biol Ther"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1161\/STROKEAHA.118.022367","volume":"49","author":"Hara S.","year":"2018","unstructured":"Hara S.; Hori M.; Murata S.; Microstructural damage in normal-appearing brain parenchyma and neurocognitive dysfunction in adult moyamoya disease. Stroke 2018,49(10),2504-2507","journal-title":"Stroke"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s00415-009-5424-8","volume":"257","author":"Festa J.R.","year":"2010","unstructured":"Festa J.R.; Schwarz L.R.; Pliskin N.; Neurocognitive dysfunction in adult moyamoya disease. J Neurol 2010,257(5),806-815","journal-title":"J Neurol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.sjbs.2019.12.016","volume":"27","author":"Zhao L.","year":"2020","unstructured":"Zhao L.; Sun W.; Liang H.; Therapeutic effect of autologous bone marrow stem cell mobilization combined with anti-infective therapy on moyamoya disease. Saudi J Biol Sci 2020,27(2),676-681","journal-title":"Saudi J Biol Sci"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.3390\/ma12122036","volume":"12","author":"Bressan E.","year":"2019","unstructured":"Bressan E.; Ferroni L.; Gardin C.; Metal nanoparticles released from dental implant surfaces: Potential contribution to chronic inflammation and peri-implant bone loss. Materials 2019,12(12),2036","journal-title":"Materials"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1021\/acs.jafc.8b07166","volume":"67","author":"D\u2019Onofrio N.","year":"2019","unstructured":"D\u2019Onofrio N.; Balestrieri A.; Neglia G.; chemistry, f., Antioxidant and Anti-Inflammatory Activities of Buffalo Milk \u03b4-Valerobetaine. J Agric Food Chem 2019,67(6),1702-1710","journal-title":"J Agric Food Chem"}],"container-title":["Current Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574888X17666220607121027","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/205684\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574888X17666220607121027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T18:33:13Z","timestamp":1693765993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/205684\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574888x17666220607121027","relation":{},"ISSN":["1574-888X"],"issn-type":[{"value":"1574-888X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-08-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}